Infection and Drug Resistance
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.2 | Q2 | 61.7% | 0.791 | Q2 | 76.9% |
| 2024 | 2.9 | Q2 | 62.8% | 0.793 | Q2 | 77.6% |
| 2023 | 2.9 | Q2 | 59.1% | 0.743 | Q2 | 77.5% |
| 2022 | 3.9 | Q2 | 70.1% | 0.840 | Q2 | 81.9% |
| 2021 | 4.2 | Q2 | 70.7% | 0.944 | Q1 | 85.4% |
| 2020 | — | — | 1.033 | Q1 | 86.0% | |
| 2019 | — | — | 0.966 | Q1 | 84.9% | |
| 2018 | — | — | 1.354 | Q1 | 90.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
1178-6973
country
NZcoverage
2009-2026